A detailed history of Russell Investments Group, Ltd. transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Russell Investments Group, Ltd. holds 229,965 shares of VRTX stock, worth $107 Million. This represents 0.16% of its overall portfolio holdings.

Number of Shares
229,965
Previous 261,151 11.94%
Holding current value
$107 Million
Previous $122 Million 12.63%
% of portfolio
0.16%
Previous 0.2%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$460.0 - $505.78 $14.3 Million - $15.8 Million
-31,186 Reduced 11.94%
229,965 $107 Million
Q2 2024

Aug 08, 2024

SELL
$392.81 - $485.53 $6.04 Million - $7.46 Million
-15,366 Reduced 5.56%
261,151 $122 Million
Q1 2024

May 08, 2024

SELL
$407.69 - $446.08 $6.01 Million - $6.57 Million
-14,733 Reduced 5.06%
276,517 $116 Million
Q4 2023

Feb 05, 2024

SELL
$343.0 - $410.68 $22.4 Million - $26.8 Million
-65,369 Reduced 18.33%
291,250 $119 Million
Q3 2023

Nov 13, 2023

SELL
$338.18 - $362.46 $1.51 Million - $1.62 Million
-4,464 Reduced 1.24%
356,619 $124 Million
Q2 2023

Aug 10, 2023

SELL
$314.42 - $351.91 $7.75 Million - $8.67 Million
-24,650 Reduced 6.39%
361,083 $127 Million
Q1 2023

May 09, 2023

BUY
$283.23 - $323.1 $4.6 Million - $5.24 Million
16,228 Added 4.39%
385,733 $122 Million
Q4 2022

Feb 08, 2023

BUY
$285.76 - $321.48 $13 Million - $14.6 Million
45,393 Added 14.01%
369,505 $107 Million
Q3 2022

Nov 04, 2022

BUY
$273.83 - $305.53 $6.01 Million - $6.71 Million
21,966 Added 7.27%
324,112 $94 Million
Q2 2022

Jul 29, 2022

SELL
$234.96 - $292.55 $8.63 Million - $10.7 Million
-36,736 Reduced 10.84%
302,146 $85 Million
Q1 2022

May 05, 2022

BUY
$221.42 - $260.97 $8.09 Million - $9.53 Million
36,521 Added 12.08%
338,882 $88.1 Million
Q4 2021

Jan 21, 2022

BUY
$177.01 - $223.45 $483,060 - $609,795
2,729 Added 0.91%
302,361 $66.5 Million
Q3 2021

Nov 08, 2021

SELL
$181.39 - $202.99 $8.18 Million - $9.15 Million
-45,095 Reduced 13.08%
299,632 $54.4 Million
Q2 2021

Aug 04, 2021

BUY
$187.49 - $221.1 $28 Million - $33 Million
149,285 Added 76.38%
344,727 $69.4 Million
Q1 2021

May 10, 2021

SELL
$207.02 - $241.31 $10.8 Million - $12.6 Million
-52,367 Reduced 21.13%
195,442 $41.9 Million
Q4 2020

Feb 08, 2021

SELL
$207.01 - $276.09 $1.76 Million - $2.34 Million
-8,491 Reduced 3.31%
247,809 $58.3 Million
Q3 2020

Nov 09, 2020

SELL
$255.65 - $303.1 $717,865 - $851,104
-2,808 Reduced 1.08%
256,300 $69.6 Million
Q2 2020

Aug 05, 2020

BUY
$225.48 - $295.8 $19.1 Million - $25 Million
84,554 Added 48.44%
259,108 $74.9 Million
Q1 2020

May 06, 2020

BUY
$199.77 - $247.81 $14.2 Million - $17.6 Million
71,011 Added 68.58%
174,554 $41.3 Million
Q4 2019

Jan 29, 2020

BUY
$166.71 - $223.91 $8.07 Million - $10.8 Million
48,437 Added 87.9%
103,543 $22.7 Million
Q3 2019

Nov 01, 2019

SELL
$166.23 - $187.09 $18.6 Million - $21 Million
-112,128 Reduced 67.05%
55,106 $9.27 Million
Q2 2019

Aug 09, 2019

SELL
$164.61 - $190.37 $9.38 Million - $10.8 Million
-56,984 Reduced 25.41%
167,234 $30.5 Million
Q1 2019

May 13, 2019

SELL
$163.73 - $194.7 $1.01 Million - $1.2 Million
-6,142 Reduced 2.67%
224,218 $41.2 Million
Q4 2018

Feb 11, 2019

SELL
$151.91 - $192.21 $717,319 - $907,615
-4,722 Reduced 2.01%
230,360 $37.9 Million
Q3 2018

Oct 26, 2018

BUY
$167.73 - $192.74 $18.2 Million - $20.9 Million
108,446 Added 85.64%
235,082 $45.2 Million
Q2 2018

Aug 08, 2018

SELL
$145.72 - $169.96 $4.76 Million - $5.55 Million
-32,675 Reduced 20.51%
126,636 $20.8 Million
Q1 2018

May 11, 2018

BUY
$151.6 - $177.13 $4.94 Million - $5.77 Million
32,557 Added 25.69%
159,311 $25.9 Million
Q4 2017

Feb 06, 2018

BUY
$137.28 - $155.55 $785,378 - $889,901
5,721 Added 4.73%
126,754 $19.2 Million
Q3 2017

Nov 07, 2017

BUY
$148.13 - $162.24 $17.9 Million - $19.6 Million
121,033
121,033 $18.4 Million

Others Institutions Holding VRTX

About VERTEX PHARMACEUTICALS INC


  • Ticker VRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 256,691,008
  • Market Cap $119B
  • Description
  • Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...
More about VRTX
Track This Portfolio

Track Russell Investments Group, Ltd. Portfolio

Follow Russell Investments Group, Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Russell Investments Group, Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Russell Investments Group, Ltd. with notifications on news.